Boots looks east

Fallon, James
December 1996
WWD: Women's Wear Daily;12/2/1996, Vol. 172 Issue 103, p8
Trade Publication
Reports on the expansion plans of London-based beauty retailer Boots Co. PLC in Europe and Asia. Opening of a branch in Ireland; Plans of opening shops in Japan, Thailand and the Netherlands; Cooperation with local retailers; Company facts.


Related Articles

  • Boots revamps Wellbeing in customer appeal revamp. Francis, Ollie // Precision Marketing;9/6/2002, Vol. 14 Issue 49, p3 

    Reports the renovation of Internet site by Boots in Great Britain. Purpose for the renovation of the site; Analysis on the effectiveness of the site by Site Intelligence; Statement on the site renovation by chief operating officer Mark Dearnley.

  • Boots opts for chp.  // Modern Power Systems;Mar96, Vol. 16 Issue 3, p11 

    Reports on Boots' plans to build a combined heat and power plant at its site at Beeston, Great Britain. Plant description.

  • Boots pulls CHF drug from pharmacy shelves. Starr, Cynthia // Drug Topics;8/16/93, Vol. 137 Issue 16, p76 

    Reports on Boots Pharmaceuticals Inc.'s recall of the drug flosequinan or Manoplax. Association with symptoms of congestive heart failure; Increased risk of mortality; Prospective Randomized Flosequinan Longevity Evaluation (PROFILE); Drug's availability on compassionate-use only basis;...

  • Boots set to go globe-trotting. Fallon, James // WWD: Women's Wear Daily;12/3/1993, Vol. 166 Issue 107, p7 

    Focuses on the Boots Co.'s global expansion plans. Marketing of private label natural cosmetics products; Dominance of beauty product marketing in the United Kingdom; Appointment of distributors in Switzerland, Austria and Germany.

  • Drug company `suppressed' publication of research. Wadman, Meredith // Nature;5/2/1996, Vol. 381 Issue 6577, p4 

    Reports on the implications of Boots Co. PLC's decision to suppress the publication of a journal article out of fear that the study's conclusions would hurt the company sales of one of its products, a thyroid drug. Results of the comparative study of Synthroid, the company's drug, and three...

  • Boots.  // Marketing (00253650);8/1/2002, p11 

    Features Boots, a largest drugstore chain in Great Britain. Company operations; Management schemes; Promotional and advertising efforts.

  • Heartbreak for Boots as Manoplax fails. Chynoweth, Emma // Chemical Week;7/28/1993, Vol. 153 Issue 3, p12 

    Speculates on the sale or closure of Nottingham, England-based Boot's prescription drug business. Company's withdrawal of congestive heart failure drug Manoplax from the market; Reason for the withdrawal; Analysts' estimates of amount to be generated by the sale.

  • Boots and the environment. Stuart, Greg // Housewares;Jun93, Issue 99, p12 

    Looks at the environmental policy development of Great Britain's Boots. Strategy; Implementation of reduce, re-use and recycle policy through line managers; `Green Teams'; Membership in environmental associations; Energy policy in 1975; Boots `World' symbol for environmental labelling; Plastic...

  • Boots rebuts sale.  // Chemical Week;2/2/1994, Vol. 154 Issue 4, p6 

    Reports on Boots' decision not to sell its prescription pharmaceuticals business. Review of the business since the company's decision to withdraw its Manoplax drug after results showed that patients receiving the heart drug were found to be more likely to die than those on placebo; Possible...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics